Advertisement The National Law Review is a proud media sponsor of the upcoming Life Sciences Strategies for Anti-Corruption & FCPA Compliance – which addresses the Unique Challenges and Risk Areas Tied to FCPA and Corruption Faced by the Pharmaceuticals, Medical Device and Biotechnology Companies Pharmaceutical and medical device companies operating overseas are particularly vulnerable to FCPA violations … Continue reading Life Sciences Strategies for Anti-Corruption & FCPA Compliance 23-24 June Washington, DC